ATX Ann: Dose Escalation Approved in ACCENT Clinical Trial of AMP945 - 11th Jan 2023, 1:50pm

annb0t

annb0t

Top 20
ATX Ann: Dose Escalation Approved in ACCENT Clinical Trial of AMP945
Price Sensitive: Y
Date: 11th Jan 2023, 1:50pm

>>> Read announcement: Google: ATX Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ATX Ann: Dose Escalation Approved in ACCENT Clinical Trial of AMP945 - 11th Apr 2023, 12:17pm
Replies
0
Views
144
annb0t
annb0t
annb0t
ATX Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 10:41am
Replies
0
Views
105
annb0t
annb0t
annb0t
ATX Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer - 30th Oct 2023, 8:17am
Replies
0
Views
76
annb0t
annb0t
annb0t
ATX Ann: Amplia Receives R&D Tax Rebate Totalling $ 2.4 Million - 19th Oct 2023, 8:15am
Replies
0
Views
72
annb0t
annb0t
annb0t
ATX Ann: AACR Ovarian Cancer Conference Presentation - 9th Oct 2023, 8:55am
Replies
0
Views
60
annb0t
annb0t
Top Bottom